ProfileGDS4132 / 202908_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 61% 62% 76% 72% 63% 63% 69% 72% 68% 68% 55% 62% 63% 68% 69% 59% 64% 66% 62% 59% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101170.99361
GSM201543Muscle PCOS pioglitazone 121168.05662
GSM201544Muscle PCOS pioglitazone 161254.39476
GSM201545Muscle PCOS pioglitazone 201235.45872
GSM201829Muscle PCOS pioglitazone 231189.79163
GSM201830Muscle PCOS pioglitazon 251186.66563
GSM201831Muscle PCOS pioglitazone 271212.7669
GSM201832Muscle PCOS pioglitazone 31211.82572
GSM201833Muscle PCOS pioglitazone 41187.54368
GSM201834Muscle PCOS pioglitazone 81201.26668
GSM201835Muscle PCOS after pioglitazone 102139.35455
GSM201836Muscle PCOS after pioglitazone 122167.38362
GSM201837Muscle PCOS after pioglitazone 162162.11763
GSM201838Muscle PCOS after pioglitazone 202197.42168
GSM201839Muscle PCOS after pioglitazone 232202.61469
GSM201840Muscle PCOS after pioglitazone 252163.0859
GSM201841Muscle PCOS after pioglitazone 272170.464
GSM201842Muscle PCOS after pioglitazone 32166.65466
GSM201843Muscle PCOS after pioglitazone 42169.32662
GSM201844Muscle PCOS after pioglitazone 82162.76859